首页 › 基金 › SILVERARC CAPITAL MANAGEMENT, LLC › SLDB

SILVERARC CAPITAL MANAGEMENT, LLC 对 SLDB 的持仓历史

SOLID BIOSCIENCES INC · 医疗保健

SILVERARC CAPITAL MANAGEMENT, LLC 在 Q3 2026 的 13F 申报中披露持有 SLDB(SOLID BIOSCIENCES INC)760,337 股,市值约 US$5.5M,约占其申报组合的 0.70%,在其申报持仓中市值排名第 38 位。 SILVERARC CAPITAL MANAGEMENT, LLC 最近 12 个申报季度中有 7 个季度披露了 SLDB 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)760.34K 股
申报持仓市值$5.50M
组合权重0.70%
首次申报Q4 2023
最近变动增持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

SILVERARC CAPITAL MANAGEMENT, LLC 对 SLDB 的持仓演变

SILVERARC CAPITAL MANAGEMENT, LLC 于 Q4 2023 首次披露 SLDB 持仓:594,855 股(约 US$3.7M)。 该持仓在 Q1 2024 达到峰值 1,325,065 股,市值约 US$17.6M。 在 7 次申报中,SILVERARC CAPITAL MANAGEMENT, LLC 2 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 760,337 股、市值约 US$5.5M,环比增持 91,887 股。。 持仓曾出现大幅变动:Q1 2024 增持约 123% (随后一个季度股价下跌 57%)、Q2 2024 减持约 64% (随后一个季度股价上涨 23%)。

逐季持仓明细

季度股数金额变化
Q4 2023 594.86K $3.65M 新进
Q1 2024 1.33M $17.65M 增持
Q2 2024 473.00K $2.68M 减持
Q3 2024 457.74K $3.19M 减持
Q1 2025 452.24K $1.67M 新进
Q2 2026 668.45K $6.68M 新进
Q3 2026 760.34K $5.50M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SLDB 与 13F 数据

SLDB(SOLID BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 45 只申报持有 SLDB,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SLDB 的基金

查看 SLDB 的全部基金持有人 →

常见问题

How long has SILVERARC CAPITAL MANAGEMENT, LLC held SLDB?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed SLDB holdings in 7 of the last 12 reported quarters, going back to Q4 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in SLDB?

As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 760.34K shares of SLDB (SOLID BIOSCIENCES INC), valued at $5.50M, representing 0.70% of its reported portfolio and ranking #38.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling SLDB?

In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in SLDB. The position peaked in Q1 2024 at 1.33M shares.

Which other funds hold SLDB?

Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.